Company Information

  

Address: 901 S. MOPAC EXPRESSWAY, STE. 250
BARTON OAKS PLAZA ONE 
City: AUSTIN 
State: TX 
Zip Code: 78746 
Telephone: (512) 942-2935 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. We believe our novel approach of utilizing human enzymes offers advantages over bacterial enzyme-based approaches including a more favorable safety profile that may provide a greater likelihood of clinical success. Our capabilities in enzyme engineering, preclinical disease modelling, and drug development in both rare genetic disease and cancer allow us to identify and advance innovative opportunities to address important unmet medical needs for the benefit of patients.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-1.82NAN/E
12/2017-1.80NAN/E
09/2017-1.75NAN/E
06/2017-1.55NAN/E
03/20174.41NA1.69
12/2016-2.22NAN/E
03/2016--NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.22Total Liab/Total Assets0.10
Net Inc/Total Assets-0.49Total Liab/Inv Cap0.11
Net Inc/Inv Cap-0.54Total Liab/Comm Equity0.05
Pretax Inc/Net Sales-5.23Interest Coverage RatioNA
Net Inc/Net Sales-5.23Curr Debt/EquityNA
Cash Flow/Net Sales-4.73LTD/EquityNA
SG&A/NetSales1.93Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover2.42Quick Ratio9.77
Inventory TurnoverNACurrent Ratio9.77
Inventory Day SalesNANet Rec/Curr Assets0.06
Net Sales/Work Cap0.11Inv/Curr AssetsNA
Net Sales/PP&E6.09  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 1.51 1.48 1.26 1.48
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 2.89 2.32 3.02 2.37
Operating Income -8.25 -6.63 -8.00 -6.72
Interest Exp NA NA NA NA
Pretax Income -8.12 -6.48 -7.87 -6.63
Other Income 0.13 0.14 0.13 0.09
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -8.12 -6.48 -7.87 -6.63

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 43.48 50.30 55.75 63.39
Receivables - Total 3.37 3.08 2.45 1.21
Inventories - Total NA NA NA NA
Total Current Assets 48.84 54.99 59.52 66.20
Net Property, Plant & Equipment 0.81 0.85 0.84 0.80
Total Assets 49.79 56.08 60.50 67.14
Liabilities        
Accounts Payable 5.77 5.61 4.83 4.35
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 5.77 5.63 4.88 4.42
Long-Term Debt NA NA NA NA
Total Liabilities 5.87 5.74 4.99 4.54
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -80.63 -72.51 -66.03 -58.16
Treasury Stock NA NA NA NA
Total Stockholders' Equity 43.92 50.34 55.51 62.60
Total Liabilities and Stockholders' Equity 49.79 56.08 60.50 67.14

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -7.45 -5.87 -7.37 -5.94
Net Cash Provided by Investing Activities 4.70 4.84 -6.29 4.52
Net Cash Provided by Financing Activities 0.69 0.68 -0.12 11.55

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20140.00-10.35--
12/20156.08-11.30--
12/20164.63-21.70-2.22
12/20175.20-27.24-1.80
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18438,47338.76




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.